Search for Clinical Trial Results

Sponsored By

Granulomatosis with Polyangiitis - 3 Studies Found

Status Study
Completed Study Name: PR3-AAV Resilient Remission or PRRR
Condition: Granulomatosis With Polyangiitis
Date: 2025-03-19
Interventions: 1000 mg per infusion given approximately two weeks apart, on day 1 and on day 15
COMPLETED Study Name: Maintenance of Remission with Rituximab Versus Azathioprine for Newly-diagnosed or Relapsing Eosinophilic Granulomatosis with Polyangiitis.
Condition: Eosinophilic Granulomatosis with Polyangiitis
Date: 2025-03-19
Interventions: pre-emptive 500-mg fixed-dose of IV rituximab every 6 months (total duration of 18 months = 4 infusions)
COMPLETED Study Name: The Assessment of Prednisone In Remission Trial - Centers of Excellence Approach
Condition: Granulomatosis With Polyangiitis
Date: 2025-03-19
Interventions: Subjects will remain on daily prednisone dose of 5 mg